Beraud Jill
Insider CIK 1520061 · NWY Director · RVNC Director · LEVI Director · TIF EXECUTIVE VICE PRESIDENT
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LEVI LEVI STRAUSS & CO | A Award deriv | 2026-08-05 | 2026-08-07 | 92 | — | $0 | 14,463 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2026-08-05 | 2026-08-07 | 54 | — | $0 | 181,261 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2026-08-05 | 2026-08-07 | 92 | — | $0 | 14,463 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2026-08-05 | 2026-08-07 | 54 | — | $0 | 181,261 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2026-05-06 | 2026-05-08 | 86 | — | $0 | 14,371 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2026-05-06 | 2026-05-08 | 50 | — | $0 | 181,207 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2026-04-22 | 2026-04-24 | 8,381 | — | $0 | 181,157 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2026-02-25 | 2026-02-27 | 89 | — | $0 | 14,285 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2026-02-25 | 2026-02-27 | 75 | — | $0 | 172,776 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2025-11-04 | 2025-11-06 | 101 | — | $0 | 14,196 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2025-11-04 | 2025-11-06 | 85 | — | $0 | 172,701 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2025-08-08 | 2025-08-12 | 97 | — | $0 | 14,095 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2025-08-08 | 2025-08-12 | 82 | — | $0 | 172,616 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2025-05-09 | 2025-05-12 | 104 | — | $0 | 13,998 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2025-05-09 | 2025-05-12 | 88 | — | $0 | 172,534 | SEC↗ |
| LEVI LEVI STRAUSS & CO | C Conversion deriv | 2025-04-23 | 2025-04-25 | 108,679 | — | $0 | 13,894 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2025-04-23 | 2025-04-25 | 11,690 | — | $0 | 172,446 | SEC↗ |
| LEVI LEVI STRAUSS & CO | C Conversion | 2025-04-23 | 2025-04-25 | 108,679 | — | $0 | 160,756 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2025-02-28 | 2025-03-04 | 99 | — | $0 | 122,573 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2025-02-28 | 2025-03-04 | 56 | — | $0 | 52,077 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 15,000 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | U Tender | 2025-02-04 | 2025-02-06 | 28,606 | $3.65 | $104.4K | 15,000 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2024-11-14 | 2024-11-18 | 106 | — | $0 | 122,474 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2024-11-14 | 2024-11-18 | 60 | — | $0 | 52,021 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2024-08-20 | 2024-08-22 | 93 | — | $0 | 122,368 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2024-08-20 | 2024-08-22 | 52 | — | $0 | 51,961 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2024-05-23 | 2024-05-28 | 74 | — | $0 | 122,275 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2024-05-23 | 2024-05-28 | 42 | — | $0 | 51,909 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2024-05-01 | 2024-05-03 | 23,458 | — | $0 | 23,458 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-05-01 | 2024-05-03 | 15,000 | — | $0 | 43,606 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2024-04-24 | 2024-04-26 | 7,642 | — | $0 | 51,867 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2024-02-23 | 2024-02-27 | 88 | — | $0 | 122,201 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2024-02-23 | 2024-02-27 | 69 | — | $0 | 44,225 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2023-11-09 | 2023-11-13 | 112 | — | $0 | 122,113 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2023-11-09 | 2023-11-13 | 87 | — | $0 | 44,156 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2023-08-17 | 2023-08-21 | 113 | — | $0 | 122,001 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2023-08-17 | 2023-08-21 | 88 | — | $0 | 44,069 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award deriv | 2023-05-18 | 2023-05-22 | 117 | — | $0 | 121,888 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2023-05-18 | 2023-05-22 | 129 | — | $0 | 43,981 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-05-03 | 2023-05-05 | 5,915 | — | $0 | 5,915 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-05-03 | 2023-05-05 | 3,534 | — | $0 | 28,606 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2023-04-19 | 2023-04-21 | 10,251 | — | $0 | 43,852 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2023-02-23 | 2023-02-27 | 81 | — | $0 | 77,962 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2023-02-23 | 2023-02-27 | 87 | — | $0 | 77,707 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2022-11-21 | 2022-11-23 | 190 | — | $0 | 77,794 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2022-08-17 | 2022-08-18 | 152 | — | $0 | 77,604 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2022-05-24 | 2022-05-25 | 222 | — | $0 | 77,452 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-06 | 11,343 | — | $0 | 11,343 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-13 | 10,756 | — | $0 | 10,756 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-05-04 | 2022-05-06 | 6,059 | — | $0 | 25,072 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2022-04-20 | 2022-04-22 | 7,812 | — | $0 | 77,230 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2022-02-24 | 2022-02-28 | 129 | — | $0 | 69,418 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2021-11-17 | 2021-11-18 | 81 | — | $0 | 69,289 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2021-08-18 | 2021-09-02 | 94 | — | $0 | 69,208 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2021-07-15 | 2021-07-19 | 5,455 | — | $0 | 69,114 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2021-05-25 | 2021-05-26 | 72 | — | $0 | 63,659 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-05-05 | 2021-05-07 | 7,551 | — | $0 | 7,551 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-05-05 | 2021-05-07 | 4,013 | — | $0 | 19,013 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2021-02-26 | 2021-03-02 | 56 | — | $0 | 63,587 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2020-07-16 | 2020-07-20 | 12,449 | — | $0 | 63,531 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-05-14 | 2020-05-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-05-14 | 2020-05-15 | 6,000 | — | $0 | 15,000 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2020-05-08 | 2020-05-12 | 135 | — | $0 | 51,009 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2020-05-08 | 2020-06-01 | 208 | — | $0 | 51,082 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2020-02-21 | 2020-02-25 | 135 | — | $0 | 50,874 | SEC↗ |
| LEVI LEVI STRAUSS & CO | A Award | 2019-06-20 | 2019-08-09 | 7,117 | — | $0 | 50,447 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 18,000 | — | $0 | 18,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-06-04 | 2019-06-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| LEVI LEVI STRAUSS & CO | J Other deriv | 2019-03-25 | 2023-04-21 | 43,330 | — | $0 | 120,740 | SEC↗ |
| LEVI LEVI STRAUSS & CO | J Other deriv | 2019-03-25 | 2023-04-21 | 77,410 | — | $0 | 77,410 | SEC↗ |
| LEVI LEVI STRAUSS & CO | J Other | 2019-03-25 | 2023-04-21 | 77,410 | — | $0 | 43,330 | SEC↗ |
| LEVI LEVI STRAUSS & CO | J Other | 2019-03-25 | 2023-04-21 | 43,330 | — | $0 | 0 | SEC↗ |
| LEVI LEVI STRAUSS & CO | J Other deriv | 2019-03-25 | 2019-03-27 | 77,410 | — | $0 | 77,410 | SEC↗ |
| LEVI LEVI STRAUSS & CO | J Other | 2019-03-25 | 2019-03-27 | 120,740 | — | $0 | 0 | SEC↗ |
| LEVI LEVI STRAUSS & CO | J Other | 2019-03-25 | 2019-03-27 | 43,330 | — | $0 | 43,330 | SEC↗ |
| TIF TIFFANY & CO | P Buy | 2015-01-26 | 2015-01-28 | 500 | $90.71 | $45.4K | 500 | SEC↗ |
| TIF TIFFANY & CO | A Award deriv | 2015-01-14 | 2015-01-16 | 38,000 | — | $0 | 38,000 | SEC↗ |
| TIF TIFFANY & CO | A Award deriv | 2015-01-14 | 2015-01-16 | 19,400 | — | $0 | 19,400 | SEC↗ |
| NWY New York & Company, Inc. | A Award | 2014-06-16 | 2014-06-18 | 15,306 | $3.92 | $60.0K | 57,849 | SEC↗ |
| NWY New York & Company, Inc. | A Award | 2013-06-25 | 2013-06-27 | 9,600 | — | $0 | 42,543 | SEC↗ |
| NWY New York & Company, Inc. | A Award | 2012-06-25 | 2012-06-27 | 16,853 | — | $0 | 32,943 | SEC↗ |